Xtant Medical Holdings (XTNT) EPS (Weighted Average and Diluted) Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Xtant Medical Holdings | 64.46 Mn | 47.14 Mn | 17.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -72.23% |
| Sep 30, 2025 | 16.00% |
| Jun 30, 2025 | 16.05% |
| Mar 31, 2025 | 14.89% |
| Dec 31, 2024 | 31.23% |
| Sep 30, 2024 | 22.16% |
| Jun 30, 2024 | 27.52% |
| Mar 31, 2024 | 32.24% |
| Dec 31, 2023 | 63.73% |
| Sep 30, 2023 | 18.04% |
| Jun 30, 2023 | 44.51% |
| Mar 31, 2023 | 50.89% |
| Dec 31, 2022 | 74.57% |
| Sep 30, 2022 | 64.89% |
| Jun 30, 2022 | 68.48% |
| Mar 31, 2022 | 62.17% |
| Dec 31, 2021 | 71.93% |
| Sep 30, 2021 | 45.07% |
| Jun 30, 2021 | 51.43% |
| Mar 31, 2021 | 76.23% |
| Dec 31, 2020 | -30.90% |
| Sep 30, 2020 | 31.01% |
| Jun 30, 2020 | 14.26% |
| Mar 31, 2020 | 21.06% |
| Dec 31, 2019 | 23.62% |
| Sep 30, 2019 | 5.92% |
| Jun 30, 2019 | 15.59% |
| Mar 31, 2019 | 22.88% |
| Dec 31, 2018 | -12.78% |
| Sep 30, 2018 | -24.57% |
| Jun 30, 2018 | 7.13% |
| Mar 31, 2018 | -77.26% |
| Dec 31, 2017 | -179.67% |
| Sep 30, 2017 | -147.92% |
| Jun 30, 2017 | -217.67% |
| Mar 31, 2017 | -164.31% |
| Dec 31, 2016 | -174.74% |
| Sep 30, 2016 | -37.97% |
| Jun 30, 2016 | -105.89% |
| Mar 31, 2016 | -44.37% |
| Dec 31, 2015 | 57.48% |
| Sep 30, 2015 | -19.74% |
| Jun 30, 2015 | -42.41% |